Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Glial Cells

Glial Cells

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Deletion of gasdermin D promotes granulocytic myeloid-derived suppressor cell differentiation by decreased release of mitochondrial DNA to promote tumor escape.

Cancer immunology, immunotherapy : CII·2025

Same author

Association between sleep duration and frailty in older adults: Systematic review and meta-analysis of observational studies.

Archives of gerontology and geriatrics·2025

Same author

Rapid renal MR fingerprinting for characterizing chronic kidney disease: A feasibility study.

Magnetic resonance imaging·2025

Same author

Identifying Risk and Protective Factors Impacting the Clinical Outcomes of Subthreshold Anxiety in Early Adolescents: Insights From the ABCD Study.

Depression and anxiety·2025

Same author

Nr4a1 modulates inflammation and heart regeneration in zebrafish.

Development (Cambridge, England)·2025

Same author

The shared genetic structure and causal analysis between frailty and suicide.

Behavioural brain research·2025

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

Microglial cells and Parkinson's disease.

Li Qian¹, Patrick M Flood

¹Department of Microbiology, The University of North Carolina Schools of Medicine and Dentistry, Chapel Hill, NC 27599-7455, USA.

Immunologic Research

|May 31, 2008

Summary

Microglial cells drive chronic inflammation, causing dopamine neuron death in Parkinson's disease (PD). Understanding microglial activation pathways offers new therapeutic targets for PD and CNS inflammatory diseases.

Area of Science:

Neuroscience
Immunology
Cell Biology

Background:

Chronic inflammation mediated by microglial cells is central to dopamine neuron loss in Parkinson's disease (PD).
Microglial cells produce inflammatory products, contributing to the progressive neurodegeneration observed in PD.
Pro-inflammatory cytokine generation by activated microglial cells is a hallmark of PD pathology.

Purpose of the Study:

To elucidate the mechanisms underlying microglial cell activation and response in the context of PD.
To identify critical signaling pathways involved in microglial-mediated neuroinflammation.
To explore potential therapeutic targets within microglial cells for treating PD and other central nervous system (CNS) inflammatory conditions.

Main Methods:

Investigating the role of the respiratory burst pathway in microglial activation.

Related Experiment Videos

Last Updated: Jul 4, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

Analyzing signaling cascades that lead to pro-inflammatory cytokine production.

Examining the direct toxicity of microglial inflammatory products on dopamine (DA)-producing neurons.

Main Results:

Activation of the microglial respiratory burst is a key event in DA-neuron toxicity.
Specific signaling pathways mediate the inflammatory response of microglial cells in PD.
Microglial-derived inflammatory mediators directly contribute to neurodegeneration.

Conclusions:

Targeting microglial activation and inflammatory pathways presents a promising therapeutic strategy for Parkinson's disease.
Understanding microglial cell mechanisms is crucial for developing effective treatments for neuroinflammatory disorders.
Further research into microglial cell signaling can lead to novel interventions for CNS inflammatory diseases.